Company Analysis

Phathom Pharmaceuticals, Inc. (PHAT)

Nasdaq: PHAT · Pharmaceutical Preparations · Florham Park, NJ · filing with the SEC since 2019
Grade5.2
◀ Past 5.8● Present 5.1▶ Future 4.8
1 est.

Who runs Phathom Pharmaceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Basta Steven L
President and CEO. First filing Apr 2025, latest Feb 12, 2026, 0 filings in all.
Officers reporting now
4
of 11 people with a filing in the last fifteen months
Directors reporting now
7
21 people on the record since 2019
Officerssales are open-market, Oct 8, 2025 to Oct 8, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Narula SanjeevChief Financial & Bus. OfficerOct 2025Oct 8, 2026none
Breedlove Robert CharlesPrincipal Accounting OfficerMay 2025Sep 8, 20261 · $0.00
Basta Steven LPresident and CEOApr 2025Feb 12, 2026none
Cook Anne MarieChief Legal Off. & Corp. Sec.Jun 2025Feb 12, 2026none
Directorssales are open-market, Oct 8, 2025 to Oct 8, 2026
NameRoleFirst filingLatest filingSales, 12 months
Parikh AsitdirectorDec 2019May 27, 2026none
Cola Michael FdirectorOct 2019May 21, 2026none
Fields HeididirectorOct 2019May 21, 2026none
Karbe FrankdirectorApr 2022May 21, 2026none
Schroeder Theodore RdirectorApr 2025May 21, 2026none
Stenhouse MarkdirectorMar 2020May 21, 2026none
Topper James NdirectorOct 2019May 21, 2026none
Earlier names on the record26, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton PHAT · research, not advice